Price T Rowe Associates Inc Organogenesis Holdings Inc. Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 28,892 shares of ORGO stock, worth $130,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,892
Previous 28,899
0.02%
Holding current value
$130,880
Previous $93,000
34.41%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ORGO
# of Institutions
140Shares Held
67.8MCall Options Held
15.3KPut Options Held
925-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$56.5 Million4.46% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.1MShares$14 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...